Haselmeier's new facility will cover approx. 1.100 square meters including a clean room suite for the assembly of reusable pens. The manufacturing capacity can be swiftly adapted to changing market needs.
“As the incidence of diabetes is increasing significantly in India and other developing countries and with it the demand for injection pens will also increase”, commented Jochen Gabriel, Chairman of Haselmeier. He added that “device manufacturers will be faced with supplying high quality and affordable pen injectors in those countries. By establishing production in India, we will be well prepared for this challenge.”
Haselmeier India Pvt. Ltd. has been incorporated in August 2011. In the meantime, the company has acquired a suitable location and hired key personnel to prepare for production readiness within the shortest possible time.
The new facility will expand Haselmeier's manufacturing capacity, which currently consists of facilities in Germany and the Czech Republic. Haselmeier plans to build its own facility in India within the next years which will foresee vertical integration of crucial manufacturing steps, such as injection moulding and printing.